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Abstract 21 
Macrophages are a key and heterogenous class of phagocytic cells of the innate 22 
immune system, which act as sentinels in peripheral tissues and are mobilized 23 
during infection. Macrophage activation in the presence of bacterial cells and 24 
molecules entails specific and complex programs of gene expression. How such 25 
triggers elicit the gene expression programs is incompletely understood. We pre-26 
viously discovered that transcription factor TFEB is a key contributor to macro-27 
phage activation during bacterial phagocytosis. However, the mechanism linking 28 
phagocytosis of bacterial cells to TFEB activation remained unknown.  In this ar-29 
ticle, we describe a previously unknown pathway that links phagocytosis with the 30 
activation of TFEB and related transcription factor TFE3 in macrophages. We 31 
find that phagocytosis of bacterial cells causes an NADPH oxidase (PHOX)-32 
dependent oxidative burst, which activates enzyme CD38 and generates NAADP 33 
in the maturing phagosome. Phago-lysosome fusion brings Ca2+ channel 34 
TRPML1/MCOLN1 in contact with NAADP, causing Ca2+ efflux from the lyso-35 
some, calcineurin activation, and TFEB nuclear import. This drives TFEB-36 
dependent expression of important pro-inflammatory cytokines, such as IL-1α, IL-37 
1β, and IL-6. Thus, our findings reveal that TFEB activation is a key regulatory 38 
event for the activation of macrophages. These findings have important implica-39 
tions for infections, cancer, obesity, and atherosclerosis.  40 
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Introduction 41 
Macrophages are phagocytic cells of the innate immune system, which act as 42 
sentinels in peripheral tissues and are mobilized during infection 1. Macrophages 43 
are activated in the presence of bacteria, which entails specific programs of gene 44 
expression. Depending on the stimulus and the microenvironment, particularly 45 
the pathogen molecules and cytokines present, macrophages adopt phenotypes 46 
(or “polarize”) along a spectrum, from “classical” activation (a.k.a. M1 polariza-47 
tion), which is predominantly pro-inflammatory, to “alternative” activation (a.k.a. 48 
M2 polarization), which is predominantly pro-resolution 2. The activation state of 49 
the macrophage has great functional consequences for health and disease. 50 
 51 
Because transcriptional regulation contributes greatly to the macrophage phe-52 
notype, understanding the transcription factors that are involved is of paramount 53 
importance. Similarly, it is imperative to fully elucidate the signaling pathways 54 
that regulate such transcription factors under conditions of homeostasis and dis-55 
ease. Much work has characterized important signaling from the Toll-like recep-56 
tors (TLRs), which recognize molecules produced by pathogens such as bacteri-57 
al cell wall components and trigger the activation of transcription factors NF-κB, 58 
IRF3, and AP1 3. All three examples of transcription factors are subject to multi-59 
ple regulatory layers, nuclear-cytoplasmic shuttling being a major mechanism of 60 
regulation. 61 
 62 
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We recently identified TFEB as a transcription factor that is important for cyto-63 
kine and chemokine gene induction in macrophages following bacterial infection 64 
4
. We found that TFEB resides in the cytosol in resting murine macrophages, but 65 
is imported to the nucleus after short infection with Staphylococcus aureus or 66 
Salmonella Typhimurium 4,5. Moreover, cells defective in TFEB expression exhibit 67 
defective induction of important pro-inflammatory cytokines, including TNF-α, IL-68 
1β, and IL-6 4. Subsequent studies confirmed our initial observations, and ex-69 
tended them by showing that TFE3 is also activated by lipopolysaccharide (LPS), 70 
a cell wall constituent of Gram-negative bacteria 6. Moreover, an independent 71 
study demonstrated how phagocytosis of opsonized particles triggers TFEB nu-72 
clear import and the subsequent activation of bactericidal mechanisms in murine 73 
macrophages 7. Thus, clearly activation of TFEB is an important regulatory event 74 
in macrophage responses to bacterial pathogens. However, the regulatory 75 
mechanisms upstream of TFEB during bacterial infection in macrophages re-76 
mained unclear. 77 
 78 
We recently reported a novel pathway that is required for TFEB activation dur-79 
ing bacterial infection in macrophages 5. In it, phosphatidyl choline-directed 80 
phospholipase C (PC-PLC), which produces diacyl glycerol (DAG), activates pro-81 
tein kinase D1 (PrKD1) to promote TFEB nuclear import. While in the absence of 82 
this pathway TFEB cannot be activated by infection, its induction is sufficient to 83 
cause TFEB nuclear import. However, the molecular mechanism linking PrKD1 84 
to TFEB remained unknown. Importantly, the link between phagocytosis of bacte-85 
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ria and PC-PLC/PrKD1 activation remained unclear. 86 
 87 
In the present article, we describe the discovery of a novel pathway that links 88 
phagocytosis of bacterial cells to TFEB activation and downstream cytokine ex-89 
pression. Instead of the expected TLR signaling pathways, we found that signal 90 
transduction for TFEB activation requires NADPH oxidase (PHOX) and the pro-91 
duction of reactive oxygen species (ROS). This event sets in motion the activa-92 
tion of CD38, which produces NAADP, an activating ligand for lysosomal Ca2+ 93 
export channel TRPML1/MCOLN1. TRPML1/MCOLN1 activation, followed by 94 
Ca2+ export, drives calcineurin, a Ca2+-regulated protein phosphatase that 95 
dephosphorylates TFEB on conserved S/T residues critical for TFEB cytosolic 96 
sequestration 8, thus allowing TFEB nuclear import and downstream gene induc-97 
tion. 98 
 99 
Because of the broad tissue expression of CD38 and other components of this 100 
pathway 9, and because several stresses and diseases cause potentially TFEB-101 
activating ROS production from mitochondria 10–12, the findings reported here are 102 
likely to have broad implications for the regulation of gene expression down-103 
stream of TFEB in multiple tissues and physiological conditions, including home-104 
ostasis and inflammatory diseases.  105 
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Results 106 
Phagocytosis of Gram+ and Gram- bacteria activates TFE3 in macro-107 
phages 108 
We previously showed that S. aureus and S. Typhimurium could activate 109 
TFEB in murine macrophages 5. Since then, several studies have suggested that 110 
TFE3 and TFEB share many features of upstream regulation 13–15. In addition, 111 
previous work showed that extended incubation with LPS activates TFE3 in mac-112 
rophages 6. Therefore, we wondered if TFE3 might also respond to infection by 113 
bacteria. We found that infection with S. aureus or S. Typhimurium activated 114 
TFE3 with similar kinetics and amplitude as TFEB, measured by its nuclear ac-115 
cumulation (Fig. 1A-H and S1A-C, F). Moreover, peptidoglycan (PGN) from S. 116 
aureus alone was sufficient to induce TFE3 and TFEB nuclear accumulation 117 
(Fig. 1C, F-H), suggesting that phagocytosis of large particles was not a re-118 
quirement. Both S. aureus and PGN also induced the formation of lysosomes, 119 
measured with Lysotracker staining (Fig. 1I-R). There was a striking correlation 120 
between nuclear accumulation of TFEB and lysosome induction, indicating that 121 
S. aureus- or PGN-induced TFEB activation was biologically relevant. 122 
 123 
Salmonella infection produced a more nuanced response. As we previously 124 
showed, live and dead Salmonella differed in their ability to induce TFEB activa-125 
tion 5. While live Salmonella induced rapid activation of TFEB and TFE3, dead 126 
Salmonella did so much more slowly (Fig. S1A-D, F, G). Interestingly, the kinet-127 
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ics of TFEB and TFE3 activation by dead Salmonella resembled that of LPS, 128 
suggesting that they might trigger TFEB/3 activation through a similar sensing 129 
mechanism (Fig. S1E, H). In contrast to S. aureus, Salmonella did not induce the 130 
accumulation of lysosomes, but rather decreased it below baseline (Fig. S2A). 131 
LPS induced lysosomal accumulation, as PGN did (Fig. S2C). Thus, we suspect 132 
that Salmonella possesses a mechanism to inhibit lysosomal biogenesis down-133 
stream of TFEB/3. This is consistent with previous results showing lysosomal in-134 
hibition by Salmonella 16,17. 135 
 136 
The overall conclusion of these observations is that bacterial infection and 137 
bacterial ligand stimulation of murine macrophages causes biologically significant 138 
TFEB and TFE3 activation. However, the functional consequences of bacterially-139 
induced TFEB and TFE3 nuclear import were unclear. 140 
 141 
TFEB and TFE3 are key contributors to the macrophage transcriptional 142 
response to infection 143 
To better understand the functional consequences of TFEB and TFE3 activa-144 
tion during bacterial infection, we performed RNAseq of a RAW264.7 murine 145 
macrophage cell line harboring deletions in Tfeb and Tfe3. We detected induction 146 
of 1,022 genes after 3 h of S. aureus infection in wild type macrophages (Table 147 
S1, Fig. 2A). Compared to wild type cells, Tfeb-/- Tfe3-/- (double knockout, or 148 
dKO) cells exhibited a drastically altered transcription profile (Fig. 2A, C). Over-149 
.CC-BY-NC-ND 4.0 International licenseIt is made available under a 
(which was not peer-reviewed) is the author/funder, who has granted bioRxiv a license to display the preprint in perpetuity.
The copyright holder for this preprint. http://dx.doi.org/10.1101/669325doi: bioRxiv preprint first posted online Jun. 13, 2019; 
  8 
all, about two-thirds of S. aureus-induced genes in wild type macrophages were 150 
not induced in dKO cells (Fig. 2D), indicating that a large majority of the tran-151 
scriptional response to S. aureus was TFEB/3-dependent. In addition, while wild 152 
type macrophages induced Ccl5, Nos2, Ptgs2, and Tnf, indicating a classically-153 
activated state, dKO cells were completely defective in their induction (Fig. 2B). 154 
This revealed that macrophage polarization to the classically activated state, or 155 
M1, requires TFEB and/or TFE3.  156 
 157 
A large group of innate immunity genes exhibited decreased expression in 158 
dKO cells (Fig. 2C). Noteworthy examples included TLR genes Tlr6, Tlr9, and 159 
Tlr13, NF-κB transcription factor genes Nfkb2 and Rel, NF-κB inhibitor genes 160 
Nfkbib and Nfkbie, and NLR genes Nod1, Nod2, Naip2, and Naip5. In addition, 161 
several cytokine genes exhibited defective expression, including Tnf, Il1b, Il6, 162 
Ifnb1, Tgfb1, Csf1, Csf2, and Csf3, and various interleukins (e.g. Il23a, Il27, and 163 
Il33), as well as chemokines and chemokine receptors such as Ccl3, Ccl6, Ccl7, 164 
Ccl12, Ccl17, Ccl22, Cxcl3, Cxcl10, Cxcl11, Ccrl2, Cx3cr1, and signaling compo-165 
nents such as Ripk2, Jak3, Stat1, Stat2, and Stat5a. Moreover, several autopha-166 
gy and lysosomal genes showed lower expression: Cathepsins (lysosomal prote-167 
ases Ctsa, Ctsd, Ctse, Ctsz), Sqstm1, Mcoln1 and Mcoln2, Atg7, Atg13, Irgm1 168 
and Irgm2, and Map1lc3a (LC3). Finally, expression of ER unfolded protein re-169 
sponse transcription factor gene Xbp1 and necroptosis effector gene Mlkl were 170 
also reduced in dKO macrophages. These results strongly suggest that TFEB/3 171 
are important for many key functions of macrophages, including pathogen recog-172 
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nition, pro-inflammatory signaling, secretion of chemotactic signals, and autoph-173 
agy/lysosomal clearance.  174 
 175 
More systematically, analysis of over-represented Reactome pathways 18 re-176 
vealed that the top affected categories were “Cytokine Signaling in Immune Sys-177 
tem”, “Signaling by Interleukins”, and “Innate Immune System”. Other significant 178 
categories affected were “Interferon signaling”, “ER-Phagosome Pathway”, and 179 
various TLR pathways (Fig. 2E). Consistent with the transcriptome measure-180 
ments, we observed robust secretion of IL-6 in S. aureus-infected wild type mu-181 
rine macrophages, which was abrogated by deletion of Tfeb alone (Fig. 2F, H). 182 
Wild type cells also secreted more IL-1β and TNF-α than TfebΔLysM macrophages, 183 
even though in this case the secreted levels were noisier than IL-6 (Fig. 2H, J). 184 
IL-1α exhibited a similar trend to IL-1β (Fig. 2G). Lactate dehydrogenase (LDH) 185 
release assays ruled out that these differences were due to cytotoxicity (Fig. 2K). 186 
Together, these observations provide strong evidence that TFEB/3 are essential 187 
for the macrophage transcriptional response to S. aureus infection, for macro-188 
phage polarization and function, and for the production of pro-inflammatory cyto-189 
kines and chemokines. They also suggest that Tfeb deletion alone is sufficient to 190 
confer a defect in cytokine production, consistent with previous results 6. There-191 
fore, nuclear translocation of TFEB and TFE3 is a key regulatory event for the 192 
macrophage response to infection. However, the signaling events upstream of 193 
TFEB/3 activation remained undefined. 194 
 195 
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Bacterial infection activates TFEB and TFE3 independently of TLR sig-196 
naling 197 
Because TLRs constitute a major mechanism of innate recognition of bacterial 198 
ligands, we investigated the roles of TLR signaling in TFEB activation by bacteri-199 
al cells and ligands. MyD88 is a protein adaptor that is important for signaling 200 
from TLR2/6 and TLR4, which detect PGN and LPS, respectively 19. TRIF is an 201 
adaptor that is also important for signaling from endosomal TLR4 20.Together, 202 
MyD88 and TRIF are essential for TLR signaling. Therefore, we examined TFEB 203 
activation in murine macrophages lacking both MyD88 and TRIF. 204 
 205 
Much to our surprise, after infection with S. aureus and treatment with PGN 206 
Myd88-/- Trif-/- macrophages exhibited the same levels of TFEB activation as wild 207 
type cells (Fig. 3). Similarly, after infection with Salmonella or treatment with 208 
TLR4 agonists LPS or MPLA we observed no difference between Myd88-/- Trif-/- 209 
and wild type macrophages (Fig. S2). These results suggested that TLR signal-210 
ing is dispensable for TFEB activation by bacterial cells and ligands, regardless 211 
of cell wall structure. 212 
 213 
To test this conclusion further, we examined TFEB activation in macrophages 214 
deficient for TLR2 and TLR4 (Fig. S3A, B). After infection with S. aureus and 215 
PGN or Pam3Csk4 treatment, Tlr2-/- macrophages exhibited the same activation 216 
of TFEB as wild type cells (Fig. S3C-L). Likewise, after infection with live Salmo-217 
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nella or treatment with LPS, TFEB activation in Tlr4-/- and wild type macrophages 218 
was indistinguishable; MPLA still activated TFEB in Tlr4-/- cells, albeit more weak-219 
ly (Fig. S3M-X). Together, these results indicated that bacterial cells and ligands 220 
activate TFEB by a TLR-independent pathway. 221 
 222 
Bacterial activation of TFE3 requires the PC-PLC/PrKD1 pathway 223 
Given this lack of relevance of TLR signaling, we sought alternative mecha-224 
nisms of TFE3 activation. We previously showed that TFEB activation in macro-225 
phages infected with S. aureus or Salmonella required the activity of a pathway 226 
upstream of PrKD1 5. We found that prior inhibition of PC-PLC with D609 or of 227 
PrKD with kb-NB142-70 completely abrogated TFE3 activation by Salmonella, 228 
LPS, and S. aureus, similar to TFEB (Fig. S4A-N). Furthermore, we observed 229 
strong TFE3 activation by the DAG analog PMA, which was prevented by PrKD 230 
inhibition (Fig. S4O, P). Together, these data indicate that the PC-PLC/PrKD1 231 
pathway is necessary and sufficient for TFE3 activation during infection in mac-232 
rophages, as we previously showed for TFEB. However, the connection between 233 
PrKD1 and TFEB (or TFE3) nuclear import remained unclear. More importantly, 234 
the mechanism connecting phagocytosis of bacteria to TFEB/3 activation re-235 
mained unknown. Therefore, we decided to examine regulatory events more 236 
proximal to TFEB. 237 
 238 
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Bacterial activation of TFEB requires the TRPML1/MCOLN1 – Ca2+ – 239 
calcineurin pathway 240 
The Ca2+-dependent protein phosphatase calcineurin was recently shown to 241 
be principally responsible for TFEB nuclear import induced by starvation in HeLa, 242 
HEK293, and human fibroblasts, as well as mouse muscle and MEFs. Such ef-243 
fect was mediated by its dephosphorylation of mTORC1 target sites in TFEB 21. 244 
However, the role of calcineurin in TFEB control in infected macrophages has not 245 
been tested before. Therefore, we evaluated TFEB activation in infected macro-246 
phages lacking calcineurin function. Prior incubation with Ca2+-chelating agent 247 
BAPTA prevented TFEB activation by S. aureus (Fig. 4A-E), suggesting that in-248 
tracellular Ca2+ is important. Moreover, prior treatment with calcineurin inhibitor 249 
FK506 prevented S. aureus-triggered TFEB activation even more effectively (Fig. 250 
4D, E), suggesting that calcineurin activity was required. Furthermore, siRNA-251 
mediated silencing of genes Ppp3cb, which encodes calcineurin catalytic subunit 252 
β, or Ppp3r1, which encodes calcineurin regulatory subunit Bα, abrogated TFEB 253 
activation by S. aureus (Fig. 4F-L). These experiments indicate that calcineurin 254 
is required for TFEB activation during S. aureus phagocytosis. We found similar 255 
results during infection with Salmonella (Fig. S5A-L), indicating that calcineurin is 256 
a general requirement for TFEB activation during infection of macrophages. Fur-257 
thermore, the Ca2+ ionophore ionomycin was sufficient to trigger TFEB nuclear 258 
import in uninfected macrophages (Fig. 4M-O). Thus, activation of calcineurin is 259 
necessary and sufficient for TFEB nuclear import in macrophages during infec-260 
tion with S. aureus or Salmonella. 261 
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 262 
Previous studies have identified TRPML1/MCOLN1 as a major Ca2+ export 263 
channel in lysosomes 22. Furthermore, TRPML1/MCOLN1 was shown to function 264 
upstream of calcineurin for TFEB activation in several human and mouse cell 265 
types during nutrient starvation, and TRPML1/MCOLN1 was required for TFEB 266 
activation by FcγR during phagocytosis of opsonized beads in murine macro-267 
phages 7,21. In our hands, silencing of Mcoln1 completely prevented TFEB activa-268 
tion and lysosome induction by S. aureus (Fig. 4P-T) and Salmonella (Fig. S5M-269 
Q). Conversely, treatment of uninfected macrophages with TRPML1/MCOLN1 270 
agonist ML-SA1 23 resulted in strong TFEB nuclear import (Fig. 4U-W). Thus, in 271 
macrophages TRPML1/MCOLN1 is necessary and sufficient for TFEB activation 272 
during infection. Together, these results suggested that the TRPML1/MCOLN1-273 
calcineurin-TFEB pathway is functional in macrophages, and is necessary and 274 
sufficient for TFEB nuclear import during infection. However, the mechanism of 275 
TRPML1/MCOLN1 activation during infection remained unknown. 276 
 277 
CD38 functions upstream of TRPML1/MCOLN1 for TFEB activation 278 
Because of its relevance to lysosomal storage disorders, in particular 279 
mucolipidosis Type IV, the regulation of TRPML1/MCOLN1 is of great interest 22. 280 
Recently, it was reported that nicotinic acid adenine dinucleotide phosphate 281 
(NAADP) can function as a TRPML1/MCOLN1 ligand to induce lysosomal Ca2+ 282 
export in several cell types 24,25. Therefore, we investigated whether NAADP 283 
might function to induce TFEB activation downstream of MCOLN1 during infec-284 
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tion in macrophages. 285 
 286 
Prior treatment with the potent NAADP antagonist Ned-19 26 rendered macro-287 
phages unable to translocate TFEB into the nucleus during infection with S. 288 
aureus (Fig. 5A-C, F). Likewise, treatment with kuromanin or apigenin, which in-289 
hibit the NAADP-synthesizing enzyme CD38 27,28, also prevented TFEB activa-290 
tion by S. aureus (Fig. 5D-F). We obtained essentially the same results with 291 
Salmonella (Fig. S6A-F). Moreover, silencing of Cd38 prevented TFEB activation 292 
by S. aureus (Fig. 5G-J). Together, these data showed that CD38 and NAADP 293 
were required for TFEB activation during infection. Conversely, treatment of mac-294 
rophages with the NAADP analog NAADP-AM 29 resulted in strong induction of 295 
TFEB nuclear import (Fig. 5K, L, N). Together, these observations showed that 296 
CD38 and its product NAADP are necessary and sufficient for TFEB activation by 297 
S. aureus in macrophages. In contrast, NAADP-AM-induced TFEB activation was 298 
abrogated by silencing Mcoln1 (Fig. 5M, N), suggesting that CD38 and NAADP 299 
require TRPML1/MCOLN1 to induce TFEB translocation, consistent with their 300 
proposed roles upstream of TRPML1/MCOLN1. 301 
 302 
Immunofluorescence in untreated macrophages showed that CD38 localized 303 
principally to the plasma membrane, as previously shown in several human lym-304 
phocyte cell types 30,31. In contrast, S. aureus-infected macrophages exhibited 305 
intracellular staining in what appeared to be cytosolic vesicles (Fig. 5O, P). Such 306 
vesicles are presumably phagosomes 32. We also noticed increased staining in 307 
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infected cells compared to baseline. To further examine this, we performed 308 
immunoblots. In wild type macrophages, we observed a slight increase in CD38 309 
expression, albeit of a smaller molecular weight form (45 kDa v 64 kDa), in in-310 
fected cells compared to control (Fig. 5Q). This increased expression occurred in 311 
Tfeb-/- cells as well (Fig. 5Q). Together, these observations suggested that infec-312 
tion caused the relocalization of CD38 to endomembranes, its increased expres-313 
sion, and its presumed proteolytic conversion to a smaller form in a TFEB-314 
independent manner. 315 
 316 
ROS function upstream of CD38 and of TFEB and TFE3 317 
CD38 is a fascinating transmembrane enzyme with complex membrane topol-318 
ogy, subcellular localization, and regulation 31. Upstream regulation of CD38 is 319 
poorly understood. It is thought that CD38 can be activated by reactive oxygen 320 
species (ROS) by an unknown mechanism 33,34. Moreover, ROS activated 321 
TRPML1/MCOLN1 in HEK293 cells, presumably through CD38 35. Therefore, we 322 
investigated the role of ROS in TFEB activation during infection. 323 
 324 
First, we verified the accumulation of ROS and H2O2 during infection with S. 325 
aureus in wild type macrophages (Fig. 6A, B). To our surprise, prior treatment 326 
with ROS-scavenging compounds N-acetyl cysteine (NAC) or N-acetyl cysteine 327 
aldehyde (NACA) completely prevented TFEB nuclear translocation by S. aureus 328 
(Fig. 6C-G) and Salmonella (Fig. S6G-K), suggesting that ROS were essential 329 
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for TFEB activation during infection. Conversely, treatment with CCCP, which 330 
uncouples the mitochondrial electron transport chain and elicits ROS, caused 331 
TFEB translocation in the absence of infection (Fig. 6H, I, K). Silencing of Cd38 332 
completely abrogated TFEB translocation caused by CCCP (Fig. 6J, K). Togeth-333 
er, these data indicated that ROS, generated during infection with S. aureus, are 334 
necessary and sufficient for TFEB activation by infection, in a mechanism that 335 
requires CD38. However, the source of ROS during phagocytosis remained un-336 
clear. 337 
 338 
NADPH oxidase functions upstream of the ROS-CD38-TRPML1/MCOLN1-339 
CN-TFEB axis 340 
During phagocytosis, recruitment of NADPH oxidase (PHOX) to the maturing 341 
phagosome is a key event for phagolysosome maturation and bactericidal killing 342 
36
. PHOX catalyzes the production of H2O2 from NADPH oxidation, thus initiating 343 
the production of ROS in the phagolysosome 37. Therefore, we examined PHOX 344 
as a potential source of ROS for CD38 activation during bacterial phagocytosis. 345 
 346 
First, we examined the oxidative burst in macrophages harboring a deletion in 347 
Nox2, which encodes the gp91phox subunit. While wild type macrophages in-348 
fected with S. aureus induced high levels of ROS and superoxide, Nox2-/- cells 349 
did not (Fig. 7A, B), consistent with PHOX being the main source of ROS in our 350 
infection assays. Consistent with the requirement for ROS to activate TFEB dur-351 
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ing infection, S. aureus did not induce TFEB nuclear translocation in Nox2-352 
deficient cells (Fig. 7C-G), suggesting that PHOX is required for TFEB activation 353 
by infection. In support of this conclusion, chemical inhibition of PHOX activity 354 
using apocynin completely prevented TFEB activation during S. aureus infection 355 
(Fig. H-K). We observed similar results with Salmonella (Fig. S6L-P). Together, 356 
these data suggested that PHOX functions upstream of TFEB, and that during 357 
bacterial infection its activity is essential for TFEB activation. 358 
 359 
Immunofluorescence analysis revealed that S. aureus infection caused NOX2 360 
and CD38 colocalization to increase about 100% over baseline (Fig. 7L-T). We 361 
obtained similar results with Salmonella (Fig. S6Q-T). Taken together, this series 362 
of experiments supports a hypothetical model (Fig. 7U) in which phagocytosis of 363 
bacterial cells may cause activated PHOX and CD38 to localize to the same 364 
compartment, likely the phago-lysosome. ROS produced by PHOX may cause 365 
CD38 to produce NAADP, which could activate TRPML1/MCOLN1 and induce 366 
Ca2+ export from the phago-lysosome/lysosome compartment. Ca2+ thus re-367 
leased may activate calcineurin, which can dephosphorylate TFEB. Dephosphor-368 
ylated TFEB can translocate into the nucleus, where it drives the expression of 369 
cytokines and chemokines, as previously demonstrated 4,6. In addition, TFEB ac-370 
tivation results in enhanced autophagy and lysosomal biogenesis, thus amplify-371 
ing the phagocytic capacity of the cell via a positive feedback loop, and increases 372 
the degradative capacity of the cell via a positive feedforward loop 7. However, 373 
this model did not account for the requirement of the PC-PLC/PrKD1 pathway for 374 
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TFEB activation. 375 
 376 
Disruption of PC-PLC/PrKD1 signaling inhibits TRPML1/MCOLN1 locali-377 
zation to the lysosome 378 
A previous study showed that PrKD1 is required for TRPML1/MCOLN1 379 
transport from the Golgi apparatus to the lysosome in HeLa cells and human skin 380 
fibroblasts 38. We tested if this is also a functional mechanism in macrophages. 381 
Using immunofluorescence in baseline murine macrophages, we observed low 382 
expression and localization to LAMP1-positive vesicles of TRPML1/MCOLN1 383 
(Fig. S7A-C). TRPML1/MCOLN1 expression was highly upregulated by treat-384 
ment with ML-SA1 and by infection with S. aureus (Fig. SD-I, T). Such 385 
upregulation was expected, since Mcoln1 is a direct TFEB target in macrophag-386 
es, and is upregulated by TFEB activation 6. Under S. aureus infection and ML-387 
SA1 treatment, we also observed higher colocalization of TRPML1/MCOLN1 and 388 
LAMP1 (Fig. S7D-F, J-L, S). S. aureus infection caused a 100% increase in 389 
TRPML1/MCOLN1 – LAMP1 colocalization, which was partially abrogated by 390 
prior treatment with PrKD1 inhibitor kb-NB142-70 (Fig. S7M-O, S). kb-NB142-70 391 
also prevented the induced expression of TRPML1/MCOLN1 by S. aureus and 392 
MLSA1 (Fig. S7T). Together, these observations support the notion that PrKD1 393 
is necessary for TFEB activation because it is required for TRPML1/MCOLN1 394 
transport to the phagolysosome/lysosome compartment, where it is required for 395 
Ca2+ export downstream of NAADP.  396 
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Discussion 397 
In this article, we show a novel axis for TFEB activation in macrophages dur-398 
ing phagocytosis of bacterial cells, which is essential for macrophage activation. 399 
Our observations support a model for a novel mechanism of pathogen sensing 400 
that is TLR-independent and is based on the phagocytic pathway. This pathway 401 
connects productive phagocytosis, presumably sensed by the recruitment of 402 
PHOX to the maturing phagosome. PHOX recruitment thus places the source of 403 
ROS in the same compartment as CD38, which may be endocytosed during 404 
phagocytosis of the bacterial particle. ROS generated by PHOX may activate 405 
CD38, as reported for lymphokine-activated killer cells and coronary arterial 406 
myocytes 39,40, causing the accumulation of NAADP in the phagosome. After 407 
phago-lysosome fusion, TRPML1/MCOLN1 may come into contact with this res-408 
ervoir of NAADP, thus triggering the release of lysosomal Ca2+ into the cytosol. In 409 
the cytosol, Ca2+ activates calcineurin, which dephosphorylates TFEB and ena-410 
bles its nuclear import. In the nucleus, TFEB drives the expression of a large ma-411 
jority of genes that are induced upon pathogen phagocytosis. Such gene induc-412 
tion may require direct and indirect TFEB-dependent mechanisms. As far as we 413 
can tell, TFE3 is regulated in a similar manner.  414 
 415 
Likewise, we found that bacterial molecules activate TFE3 and TFEB through 416 
a TLR-independent mechanism. These observations and the hypothetical model 417 
they support provide an explanation for previous, intriguing observations that 418 
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phagocytosis is sufficient to trigger TFEB nuclear translocation, but only if the 419 
phagocytic cup is able to close 7. In this model, ROS serve dual functions as a 420 
bactericidal agent in the phago-lysosome, and as a signal to activate CD38 and 421 
initiate the signal cascade that results in TFEB/TFE3 activation. Since both 422 
PHOX- and mitochondria-derived ROS activated TFEB and TFE3, this provides 423 
redundant mechanisms of ROS production that report on phagocytosis and mito-424 
chondrial integrity. Thus, the model predicts that any condition that leads to 425 
PHOX activation or mitochondrial disruption, increasing ROS, would result in 426 
TFEB/3 activation (at least, in macrophages). This has important implications for 427 
homeostasis and disease. 428 
 429 
Since our discovery of the key role of TFEB in the transcriptional host re-430 
sponse to infection in macrophages 4, many studies have independently shown 431 
that TFEB and/or TFE3 greatly contribute to innate immunity against a large 432 
number of bacterial pathogens 13,15,41. In addition, several signaling components 433 
have been identified in the regulation of TFEB/3, including AGS3 during LPS 434 
stimulation, the activation of TFEB by IFN-γ, and the contribution of 435 
AMPK/mTORC1 regulation by several mechanisms 42,43. Moreover, at least one 436 
example of bacterial modulation of TFEB has been elucidated, particularly how 437 
Mycobacterium tuberculosis represses TFEB through mir-33 and mir-33* 44. The-438 
se discoveries underscore the central importance of TFEB/TFE3 as key contribu-439 
tors to the host response to infection, and provide a strong rationale for complete 440 
understanding of the contributions of the novel PHOX/CD38/MCOLN1/TFEB 441 
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pathway described herein in distinct infectious diseases. 442 
 443 
The events that occur downstream of TFEB/3 activation are of considerable in-444 
terest. Prior studies demonstrated that TFEB and TFE3 have redundant and non-445 
redundant functions important for the induction of key immune signaling mole-446 
cules, such as intracellular signaling pathway components and extracellular cyto-447 
kines and chemokines in LPS-stimulated macrophages 6. Here we show that this 448 
is also true in the case of bacterial phagocytosis. Thus, TFEB/3 are predicted to 449 
be key contributors to the function of cellular networks in tissues that are under 450 
pathogenic attack, both in the induction of antimicrobial responses and in the re-451 
cruitment of effector cells of the innate and adaptive immune systems. 452 
 453 
Furthermore, we show that TFEB activation in macrophages induces 454 
lysosomal biogenesis, including the induction of TRPML1/MCOLN1 expression. 455 
Enhanced lysosomal biogenesis increases the availability of TRPML1/MCOLN1-456 
containing lysosomes for fusion with PHOX/CD38-positive maturing 457 
phagosomes, thus enacting a positive phagocytosis feedback loop. In addition, 458 
prior studies showed how TFEB activation in macrophages leads to increased 459 
autophagy 45–47, consistent with results in many other cell types. Thus, activation 460 
of the PHOX/CD38/TRPML1/CN/TFEB axis drives a positive phagocytosis 461 
feedforward loop that enhances the compartment that is poised to receive the 462 
mature phagolysosome for degradation, and enhances lysosomal exocytosis of 463 
remaining bacterial debris. 464 
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 465 
In summary, our studies reveal a heretofore unknown mechanism of macro-466 
phage activation that is activated by phagocytosis of bacterial cells. Such mech-467 
anism is parallel to better-understood TLR-mediated pathogen detection mecha-468 
nisms. A key challenge for the future is to understand how diverse pathogen-469 
detection pathways interact within an integrated regulatory network to produce a 470 
cellular response that is tailored to each particular pathogenic challenge. Addi-471 
tionally, understanding how pathogens have evolved to circumvent this new axis 472 
may help understand microbial pathogenesis and reveal new mechanisms to 473 
safely manipulate it for therapeutic purposes.  474 
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Materials and Methods 475 
Isolation and differentiation of Bone Marrow Derived macrophages 476 
(BMDMs) 477 
Femurs and tibias from 8-12 weeks old mice were separated and cleaned. 478 
Bone marrow was flushed into 50 ml tubes under the sterile hood. Bone marrow 479 
was passed through the bone until the color of the bone turned white. After cen-480 
trifugation at 1500 rpm for 5 minutes at 4 ˚C, cell pellets were resuspended and 481 
plated in BMDM media: DMEM (Fisher Scientific, MT10102CV), FBS 10% 482 
(Thermo Fisher, 16000069), AA 1% (Life Technologies, 15240-062), L-glutamine 483 
1% (Life Technologies, 25030-081), MEN NEA AA 1% (Life Technologies, 484 
11140-050), 2-Mercapto 0.1% (Life Technologies, 21985), IL-3 5 ng/ml 485 
(Peprotech: 213-13), MCSF 5 ng/ml (Peprotech: 315-02). Cell were used for ex-486 
periments after 1 week of differentiation. To produce immortalized BMDMs, cells 487 
were transformed by CreJ2 virus 48. 488 
 489 
Cell culture, transfection and Imaging  490 
RAW264.7 and iBMDM cells were grown in Dulbecco’s Modified Eagle’s Me-491 
dium (DMEM) - high glucose (Sigma-Aldrich, D6429-500ML) containing 10% en-492 
dotoxin tested FBS (Thermo Fisher, 16000044), 1% Antibiotic-Antimycotic (Life 493 
Technologies 15240-062). Cells were passage 4 to 12 times. iBMDM GFP-TFEB 494 
stably transfected cells were created using pEGFP-N1-TFEB (pEGFP-N1-TFEB 495 
was a gift from Shawn Ferguson, Addgene plasmid # 38119), Lipofectamine 496 
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3000 (Thermo Fisher, L3000008) used according to manufacturer’s instructions, 497 
and G418 sulfate (Life Technologies, 10131) used for selection. 10 days after se-498 
lection, stable cells were separated by FACS. For Imaging we used 96-Well Op-499 
tical-Bottom Plates (Thermo Fisher, 165305). 6x104 cells were seeded in each 500 
well. At the end of the experiments, cells were fixed using 4% paraformaldehyde 501 
(Sigma-Aldrich, 158127) and incubated with Hoechst stain (Anaspec, AS-83218) 502 
at room temperature for 20 minutes as nuclear staining. For lysotracker staining, 503 
LysoTracker Red DND-99 (Thermo Fisher, L7528) was added to the media 30 504 
minutes before fixing according to the manufacture instruction. Image acquisition 505 
was automatically performed using a Cytation3 Imaging Plate Reader (Biotek). 506 
The N/C ratio was measured using CellProfiler (Broad Institute), as described in 507 
5
. Colocalization analysis was performed using ImageJ software (NIH). 508 
 509 
siRNA Knockdown 510 
siRNA compounds were purchased from Dharmacon RNAi Technologies. 511 
siGENOME NonTargeting siRNA #1 (D-001210-01-05). siGENOME Mouse Cd38 512 
(12494) siRNA - SMARTpool (M-058632-01- 0005). siGENOME Mouse Ppp3cb 513 
(19056) siRNA (M-063545-00-0005). siGENOME Mouse Ppp3r1 (19058) siRNA 514 
(M-040744-01-0005). siGENOME Mouse Mcoln1 (94178) siRNA (M-044469-00-515 
0005). We used Lipofectamine RNAiMAX (Thermo Scientific, 13778030) for 516 
transfection according to manufacturer’s instructions.  517 
 518 
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Bacterial strains 519 
Salmonella enterica serovar Typhimurium SL1344 wild type is a gift from Brian 520 
Coombes (McMaster University, Canada), Staphylococcus aureus NCTC8325 is 521 
a gift from Fred Ausubel, MGH Research Institute, USA. 522 
 523 
In vitro infection 524 
Bacteria were grown overnight at 37 °C in LB medium (Difco, BD) with 100 525 
μg/ml streptomycin for Salmonella and Columbia medium (Difco, BD) with 526 
10 μg/ml Nalidixic acid for S. aureus. The following day cultures were diluted 1:50 527 
in the same medium and grown at 37 °C for 3 h to late-exponential phase, 528 
washed twice in cold PBS, and cells were infected with MOI 10 for S. aureus and 529 
MOI 10 for S. enterica, as in (Engelenburg and Palmer, 2010; Najibi et al., 2016; 530 
Trieu et al., 2009; Visvikis et al., 2014). For gentamycin antibiotic (AB) - killed 531 
bacteria, before addition to cells, gentamicin (100 µg/ml) was added to washed 532 
bacteria in PBS for 2 hours and 100% killing of the bacteria was confirmed by 533 
culture for 48 h on LB-streptomycin agar at 37°C. The appropriate amounts of 534 
bacteria were resuspended in DMEM 10 % FBS without antibiotic. 535 
 536 
Immunofluorescence 537 
After treatment, cells were fixed with 4% paraformaldehyde (PFA) pH 7.4 at 538 
room temperature for 10 min and washed 3 times in PBS (Gibco Life Technolo-539 
gies,10010) for 5 min each. PFA was neutralized with 50 mM NH4Cl in PBS at 540 
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room temperature for 10 minutes with agitation. After 3 washes with PBS, cells 541 
were permeabilized with 0.1% Triton X in PBS at room temperature on agitator 542 
for 5 min and then blocked with 5% bovine serum albumin (Sigma-Aldrich, 543 
A9647) in PBS for 1 h. After 3 washes with PBS cells were incubated with prima-544 
ry antibodies for 2 hours. Anti-TFEB Antibody (Cell Signaling, 4240). Anti-TFE3 545 
antibody (Sigma-Aldrich, HPA023881-100UL). Anti-CD38 antibody (Abcam, 546 
ab24978). Anti-NOX2/gp91phox antibody (Abcam, ab80508). Anti-LAMP1 (Cell 547 
Signaling Technology, 9091). Anti-Mucolipin 1 (MCOLN1) (C-Term) antibody 548 
(Antibodies-Online, ABIN571446). Cells were washed thrice in PBS and incubat-549 
ed with the fluorescent secondary antibody plus Hoechst stain (Anaspec, AS-550 
83218) at room temperature for 1 h. Image acquisition was performed using a 551 
Cytation3 imaging plate reader (Biotek). 552 
 553 
Immunoblotting 554 
Cells were washed 3 times with PBS, harvested, and lysed with 1X SDS sam-555 
ple buffer Blue Loading Pack (Cell Signaling, 7722) at 100 µl per well of 6-well 556 
plate. Lysates were heated at 100 °C for 5 min and then centrifuged for 5 min. 557 
The supernatant was collected and sonicated, gel electrophoresis was performed 558 
using Novex 4-20% Tris-Glycine Mini Gels (Invitrogen, XP04200BOX), and were 559 
then transferred onto nitrocellulose (Life Technologies, LC2009). After wash with 560 
TBS (Life Technologies, 28358) for 5 minutes, membranes were soaked in block-561 
ing buffer containing 1X TBS with 5% BSA for 1 hour at room temperature. After 562 
3 washes with TBS-Tween (Life Technologies, 28360), membranes were incu-563 
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bated overnight at 4 °C with primary antibodies and gentle agitation. Next mem-564 
branes were washed thrice with TBS-Tween and incubated with HRP-conjugated 565 
secondary antibody (Cell Signaling, 7074 1:2000) for 1 h at room temperature 566 
with gentle agitation. Membranes were then washed with TBS-Tween and incu-567 
bated with LumiGLO® (Cell signaling, 7003) for 1 min and exposed to x-ray film 568 
(Denville Scientific, E3012). Primary antibodies and dilutions that were used are 569 
as follows: β-actin antibody (Cell Signaling Technology, 4967, 1:1000), Anti-570 
CD38 Antibody (Cell Signaling Technology, 14637S 1:1000), Anti-TLR4 antibody 571 
(). Anti-TLR2 antibody (). Anti-Mucolipin 1 (MCOLN1) (C-Term) antibody (Anti-572 
bodies-Online, ABIN571446 1:1000). 573 
 574 
Drugs and reagents 575 
Lipopolysaccharides (LPS) from S. enterica serotype Typhimurium (Sigma-576 
Aldrich, L6143-1MG, 10ug/ml): Peptidoglycan (PGN) from S. aureus (Invivogen, 577 
tlrl-pgns2): Monophosphoryl Lipid A (MPLA-SM) (Invivogen, tlrl-mpla): ML-SA1 578 
(Sigma Aldrich, SML0627) Ionomycin (Cayman Chemical Company, 10004974): 579 
FK-506 (Cayman Chemical Company, 10007965): BAPTA AM (Cayman Chemi-580 
cal Company, 15551): Ned-19 (Cayman Chemical Company, 17527): Kuromanin 581 
(Cayman Chemical Company, 16406): Apigenin (Cayman Chemical Company, 582 
10010275): CCCP (Cayman Chemical Company, 25458): N-acetyl-L-Cysteine 583 
(NAC) (Cayman Chemical Company, 20261): N-acetyl-L-Cysteine amide (NACA) 584 
(Cayman Chemical Company, 25866): Apocynin (Cayman Chemical Company, 585 
11976):  D609 (Cayman Chemical, 13307, 50 µM): kb NB 142-70 (Cayman 586 
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Chemical Company, 18002). 587 
 588 
ROS/Superoxide Detection Assay 589 
Cellular ROS/Superoxide Detection Assay Kit (Abcam, ab139476) was used 590 
according to the manufacture instruction. Mean fluorescence intensity was calcu-591 
lated by Biotek Gen5 Data Analysis Software.    592 
 593 
RNA Sequencing and Differential Expression Analysis 594 
RAW264.7 dKO were a one-time gift from Rosa Puertollano (NHLBI). Infection 595 
was performed as described in In Vitro Infection, in three independent replicates. 596 
RNA was extracted by TRIzol Plus RNA Purification Kit (Thermo Fisher, 597 
12183555). Whole cell RNA was submitted to BGI Inc for ribosomal RNA deple-598 
tion, library construction, and sequencing on Illumina NextSeq machines. Reads 599 
were trimmed and quality-filtered by BGI. Clean reads were mapped to the 600 
GRCm38 mouse reference transcriptome using Salmon v0.13.1 and transcript-601 
quantified (Patro et al., 2017). Salmon quant outputs were analyzed using 602 
tximport and DESeq2 v1.22.2 in R (Love et al., 2014). DESeq2 output counts 603 
were used as input for interactive analysis and data plotting using DEBrowser 604 
1.10.9 in R (Kucukural et al., 2019). Differentially expressed (fold change ≥ 2; 605 
Padj ≤ 0.01; filter genes with fewer than 10 counts) gene sets were used as input 606 
for g:Profiler v0.6.6 online tools (Raudvere et al., 2019). 607 
 608 
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ELISA Assay 609 
Concentrations of IL-1α, IL-1β, IL-6 and TNF-α were measured by en-610 
zyme-linked immunosorbent assays (ELISAs) using kits purchased from R&D 611 
Systems (DY400-05, DY401-05, DY406-05, DY8234-05, DY410-05, respective-612 
ly). All incubation periods occurred at room temperature, and plates were washed 613 
with Tris buffered saline (TBS) containing 0.05% Tween 20 (Bethyl Laboratories, 614 
E106) after each step. Briefly, clear microplates (R&D Systems, DY990) were 615 
incubated overnight with capture antibody. Plates were blocked for one hour us-616 
ing TBS containing 1% BSA (Bethyl Laboratories, E104). Samples were added 617 
undiluted (IL-1α, IL-1β, IL-6) or diluted 1:10 in TBS containing 1% BSA (TNF-α) 618 
and plates were incubated for two hours. Detection antibody was added, and 619 
plates were incubated for two hours. Streptavidin-Horseradish Peroxidase (Strep-620 
HRP) was added, and plates were incubated for 20 minutes. TMB One Compo-621 
nent HRP Microwell Substrate (Bethyl Laboratories, E102) was added, and reac-622 
tion was stopped after 20 minutes using ELISA Stop Solution (Bethyl Laborato-623 
ries, E115). Optical densities were measured at 450 nm and 540 nm using 624 
SpectraMax Plus 384 Microplate Reader with SoftMax Pro software. Measure-625 
ments at 540 nm were subtracted from measurements at 450 nm to correct for 626 
optical impurities of the plates, per manufacturer’s recommendations. Concentra-627 
tions of samples were interpolated from each standard curve using Prism 8. Data 628 
are represented as mean ± SEM. 629 
 630 
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LDH Assay 631 
Lactate Dehydrogenase (LDH) activity was measured using an LDH assay kit 632 
purchased from Abcam (ab102526). LDH assay was performed following manu-633 
facturer’s guidelines. Briefly, samples were added to a clear microplate (R&D 634 
Systems, DY990). Reaction mix was made using supplied LDH Assay Buffer and 635 
LDH Substrate Mix. Reaction mix was then added to each sample. Optical densi-636 
ties were measured at 450 nm using SpectraMax Plus 384 Microplate Reader 637 
with SoftMax Pro software. The amount of NADH in each sample was interpolat-638 
ed from the standard curve using Prism 8. LDH activity was quantified by dividing 639 
the amount of NADH in each sample by the product of the reaction time in 640 
minutes and the original volume of sample added into the reaction well in mL. 641 
LDH activity was reported in mU/mL and plotted as mean ± SEM.  642 
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Figure Legends 643 
Figure 1. Gram+ bacterial cells and ligands activate TFE3. A-H. GFP-644 
TFEB immortalized BMDM (iBMDMs) were infected with S. aureus (MOI = 10) for 645 
3 h. Incubation with 10 µg/ml PGN from S. aureus was 3 h. Cells were fixed and 646 
processed for anti-TFE3 immunofluorescence staining. Shown are representative 647 
images, and quantification of three biological replicates (n = 450). A. DMSO con-648 
trol, B. S. aureus infection, and C. S. aureus PGN (10 µg/ml). D. DMSO control, 649 
E. S. aureus infection, F. S. aureus PGN. G. GFP-TFEB intensity in the nucleus 650 
compared to the cytoplasm (N/C ratio) measured using CellProfiler. **** p ≤ 651 
0.0001 (one-way ANOVA followed by Tukey’s post-hoc test).  (H) Anti-TFE3 fluo-652 
rescence N/C ratio measured using CellProfiler. **** p ≤ 0.0001 (one-way 653 
ANOVA followed by Tukey’s post-hoc test). I-N. GFP-TFEB iBMDMs were infect-654 
ed with S. aureus or incubated with S. aureus PGN as above, and stained with 655 
Lysotracker. Shown are representative images and quantification of three biolog-656 
ical replicates (n = 60). I. DMSO control. J. S. aureus infection, and K. S. aureus 657 
PGN. L-N. Higher magnification micrographs for DMSO control (L), S. aureus 658 
(M), and PGN (N). O. Lysotracker intensity per cell (MFI/cell) measured with 659 
CellProfiler. **** p ≤ 0.0001 (one-way ANOVA followed by Tukey’s post-hoc test). 660 
P-R. Comparison of Lysotracker intensities in cells with TFEB cytoplasmic locali-661 
zation (C) with that in cells with nuclear localization (N) following incubation with 662 
DMSO (P), S. aureus (Q), or PGN (R).  **** p ≤ 0.0001 (two-sample two-tailed 663 
unpaired t test).  664 
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 665 
Figure 2. TFEB and TFE3 are required for the macrophage transcriptional 666 
response to S. aureus. A-E. Wild type (WT) and Tfeb Tfe3 double knockout 667 
(dKO) RAW264.7 cells were infected as described in Methods for 3 h. N = 3 bio-668 
logical replicates. A. Heat map showing expression of genes that were differen-669 
tially expressed in wild type cells. Shown are baseline and infected conditions, in 670 
both cell lines. Two groups of genes with defective induction in dKO cells are in-671 
dicated with black boxes. B. Heat map showing expression of M1 and M2 marker 672 
genes. Colors indicate direction and magnitude of expression per row; circle di-673 
ameter is proportional to absolute expression. Grey indicates no expression de-674 
tected. C. Volcano plot showing differential gene expression in infected dKO cells 675 
relative to infected WT cells. Blue color denotes downregulation in dKO cells; red 676 
indicates upregulation in dKO cells. Green highlights noteworthy innate immunity 677 
genes, with corresponding adjacent labels. D. Pie chart showing percent of 678 
genes that are upregulated in infected v uninfected WT cells, and which are 679 
TFEB/3-dependent. E. Reactome pathway over-representation analysis of 680 
TFEB/3-dependent genes, plotting adjusted P values for each category (Padj). F. 681 
Verification of TFEB expression in Tfebflox/flox (WT) and TfebΔLysM (Tfeb-/-) iBMDMs 682 
by anti-TFEB immunoblot. G-K. Wild type (WT) and TfebΔLysM (Tfeb-/-) iBMDMs 683 
were incubated with PBS (Ctrl) or infected with S. aureus (Sa, MOI = 10). Con-684 
centrations of IL-1α (G), IL-1β (H), IL-6 (I), TNF-α (J), and lactate dehydrogenase 685 
activity (LDH, cytolysis control, K) were measured in culture supernatants 13 h 686 
following infection, by ELISA and LDH assay, respectively. N = 5-6, *p < 0.05, **p 687 
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< 0.01, ***p < 0.001, ****p < 0.0001, one-way ANOVA followed by Tukey’s post-688 
hoc test.  689 
 690 
Figure 3. TLR signaling is dispensable for TFEB activation. A-N. Primary 691 
BMDMs from WT and Myd88 Trif double knockout mice (Myd88 Trif dKO) were 692 
infected, fixed, and processed for anti-TFEB immunofluorescence staining. TFEB 693 
fluorescence N/C ratio per cell was measured using CellProfiler (n = 250). Shown 694 
are representative images and quantification of three biological replicates. A, B. 695 
DMSO control (t = 6 h); C, D. Salmonella Typhimurium (St; MOI = 1, t = 6 h). E, 696 
F. Monophosphoryl lipid A (MPLA, 1 µg/ml, t = 6 h). G, H. Salmonella 697 
Typhimurium lipopolysaccharide (LPS, 1 µg/ml, t = 6 h). I, J. S. aureus (Sa, MOI 698 
= 10, t = 3 h). K, L. S. aureus peptidoglycan (PGN, 10 µg/ml, t = 3 h). M, N. 699 
Quantification of TFEB N/C ratio per cell in WT (M) and Myd88 Trif dKO (N) cells. 700 
*** p ≤ 0.001 (one-way ANOVA followed by Tukey’s post-hoc test). 701 
 702 
Figure 4. TFEB activation is mediated by TRPML1/MCOLN1, Ca2+, and 703 
calcineurin. A-E. GFP-TFEB iBMDMs were treated with DMSO without infection 704 
(t = 3 h, A) or treated for 3 h and subsequently infected with S. aureus (B, MOI = 705 
10, t = 3 h). In parallel, cells were treated with BAPTA (C, 10 μM, t = 3 h) or 706 
FK506 (D, 5 μM, t = 6 h) and subsequently infected with S. aureus (MOI = 10, t = 707 
3 h). E. Quantification of GFP-TFEB N/C Ratio by CellProfiler (3 biological repli-708 
cates, n = 350 cells). **** p ≤ 0.0001 (one-way ANOVA followed by Tukey’s post-709 
hoc test). F-K. GFP-TFEB iBMDMs were treated with scrambled (Scr, F) or 710 
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siRNA against Ppp3cb (G), Ppp3r1 (H) for 48 h. Cells were treated with Scr (I), 711 
Ppp3cb (J), or Ppp3r1 (K) siRNA for 48 h prior to infection with S. aureus (MOI = 712 
10, t = 3 h). L. GFP-TFEB N/C Ratio by CellProfiler (3 biological replicates, n = 713 
210 cells). *** p ≤ 0.001 (one-way ANOVA followed by Tukey’s post-hoc test). M, 714 
N. GFP-TFEB iBMDMs were treated with DMSO (M, t = 6 h) or Ionomycin (N, 10 715 
μM, t = 6 h). O. GFP-TFEB N/C Ratio by CellProfiler (3 biological replicates, n = 716 
350 cells). **** p ≤ 0.0001 (one-way ANOVA followed by Tukey’s post-hoc test). 717 
P-S. GFP-TFEB iBMDMs were treated with scrambled (Scr, P) or siRNA against 718 
Mcoln1 (Q) for 48 h. Cells were treated with Scr (R) or Mcoln1 (S) siRNA for 48 h 719 
prior to infection with S. aureus (MOI = 10, t = 3 h). T. GFP-TFEB N/C Ratio by 720 
CellProfiler (3 biological replicates, n = 300 cells). *** p ≤ 0.001 (one-way ANOVA 721 
followed by Tukey’s post-hoc test). U, V. GFP-TFEB iBMDMs were treated with 722 
DMSO (U, t = 3 h) or ML-SA1 (V, 10 μM, t = 3 h). W. GFP-TFEB N/C Ratio by 723 
CellProfiler (3 biological replicates, n = 355 cells). **** p ≤ 0.0001 (two-sample 724 
two-sided t test). 725 
  726 
Figure 5. CD38 activates TFEB through NAADP and TRPML1/MCOLN1. A-727 
E. GFP-TFEB iBMDMs were treated with DMSO without infection (DM., t = 6 h, 728 
A) or treated for 6 h and subsequently infected with S. aureus (B, MOI = 10, t = 3 729 
h). In parallel, cells were treated with Ned-19 (C, Ned., 10 μM, t = 4 h), 730 
Kuromanin (D, Kuro., 100 μM, t = 6 h), or Apigenin (E, Api., 100 μM, t = 6 h) and 731 
subsequently infected with S. aureus (MOI = 10, t = 3 h). F. Quantification of 732 
GFP-TFEB N/C Ratio by CellProfiler (3 biological replicates, n = 200 cells). **** p 733 
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≤ 0.0001 (one-way ANOVA followed by Tukey’s post-hoc test). G-I. GFP-TFEB 734 
iBMDMs were treated with scrambled (Scr, G) or siRNA for 48 h. Cells were 735 
treated with Scr (H) or Cd38 (I) siRNA for 48 h prior to infection with S. aureus 736 
(MOI = 10, t = 3 h). J. GFP-TFEB N/C Ratio by CellProfiler (3 biological repli-737 
cates, n = 350 cells). *** p ≤ 0.001 (one-way ANOVA followed by Tukey’s post-738 
hoc test). K-M. GFP-TFEB iBMDMs were treated with DMSO (DM., t = 2 h, K) or 739 
treated with scrambled siRNA (Scr, t = 48 h) and subsequently incubated with 740 
NAADP-AM (100 nM, t = 2 h, L). In parallel, cells were treated with Mcoln1 741 
siRNA (t = 48 h) and subsequently incubated with NAADP-AM (100 nM, t = 2 h, 742 
M). N. Quantification of GFP-TFEB N/C Ratio by CellProfiler (3 biological repli-743 
cates, n = 300 cells). **** p ≤ 0.0001 (one-way ANOVA followed by Tukey’s post-744 
hoc test). O, P. CD38 immunofluorescence in wild type primary BMDM. PBS con-745 
trol (O) and S. aureus infection (MOI = 10, t = 2 h, P). Q. CD38 immunoblot of 746 
whole cell lysates from wild type and TfebΔLysM (Tfeb-/-) iBMDMs incubated with 747 
PBS or infected with S. aureus (MOI = 10, t = 3 h). β-actin is loading control. 748 
Representative of three biological replicates. 749 
 750 
Figure 6. ROS activate TFEB through CD38. ROS (A) and superoxide (B) 751 
generated in wild type primary BMDM during infection with S. aureus (MOI = 10, t 752 
= 1 h) shown as mean fluorescence intensity (MFI) per cell and measured with 753 
Gen5 (n = 50 cells, 3 biological replicates). **** p ≤ 0.0001 (two-sided two-sample 754 
t test). C-F. GFP-TFEB iBMDMs were treated with DMSO without infection (DM., 755 
t = 4 h, C) or treated for 4 h and subsequently infected with S. aureus (D, MOI = 756 
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10, t = 3 h). In parallel, cells were treated with NAC (E, 5 mM, t = 4 h) or NACA 757 
(F, 1 mM,  t = 4 h) and subsequently infected with S. aureus (MOI = 10, t = 3 h). 758 
G. Quantification of GFP-TFEB N/C Ratio by CellProfiler (3 biological replicates, 759 
n = 250 cells). *** p ≤ 0.001, **** p ≤ 0.0001 (one-way ANOVA followed by 760 
Tukey’s post-hoc test). H-J. GFP-TFEB iBMDMs were treated with DMSO (DM., t 761 
= 3 h, H) or treated with scrambled siRNA (Scr, t = 48 h) and subsequently incu-762 
bated with CCCP (10 μM, t = 3 h, I). In parallel, cells were treated with Cd38 763 
siRNA (t = 48 h) and subsequently incubated with CCCP (10 μM, t = 3 h, J). K. 764 
Quantification of GFP-TFEB N/C Ratio by CellProfiler (3 biological replicates, n = 765 
355 cells). **** p ≤ 0.0001 (one-way ANOVA followed by Tukey’s post-hoc test).  766 
   767 
Figure 7. Infection induced ROS and TFEB activation require NADPH ox-768 
idase. ROS (A) and superoxide (B) generated in wild type and Nox2-/- primary 769 
BMDM during infection with S. aureus (MOI = 10, t = 1 h) shown as mean fluo-770 
rescence intensity (MFI) per cell and measured with Gen5 (n = 200 cells, 3 bio-771 
logical replicates). **** p ≤ 0.0001 (two-sided two-sample t test). C-F. TFEB im-772 
munofluorescence in wild type and Nox2-/- primary BMDM. PBS controls (C, E) 773 
and infected cells (MOI = 10, t = 3 h, D, F). G. Quantification of TFEB N/C Ratio 774 
by CellProfiler (3 biological replicates, n = 200 cells). *** p ≤ 0.001, ns: p = 775 
0.4399 (one-way ANOVA followed by Tukey’s post-hoc test). H-J. GFP-TFEB 776 
iBMDMs were treated with DMSO without infection (DM., t = 4 h, H) or treated for 777 
4 h and subsequently infected with S. aureus (I, MOI = 10, t = 3 h). In parallel, 778 
cells were treated with Apocynin (J, 10 μM, t = 4 h) and subsequently infected 779 
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with S. aureus (MOI = 10, t = 3 h). K. Quantification of GFP-TFEB N/C Ratio by 780 
CellProfiler (3 biological replicates, n = 250 cells). *** p ≤ 0.001 (one-way ANOVA 781 
followed by Tukey’s post-hoc test). L-S. Immunofluorescence detection of NOX2 782 
and CD38 in wild type primary BMDM. Cells were incubated with PBS (L-O) or 783 
infected with S. aureus (MOI = 10, t = 3 h, P-S). T. Colocalization analysis of 784 
NOX2 and CD38. **** p ≤ 0.0001 (two-sided two-sample unpaired t test). U. Pro-785 
posed hypothetical model for the phagocytosis-triggered activation of TFEB. 786 
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